210 related articles for article (PubMed ID: 37342563)
1. Identification of differentially expressed HERV-K(HML-2) loci in colorectal cancer.
Kang Q; Guo X; Li T; Yang C; Han J; Jia L; Liu Y; Wang X; Zhang B; Li J; Wen HL; Li H; Li L
Front Microbiol; 2023; 14():1192900. PubMed ID: 37342563
[TBL] [Abstract][Full Text] [Related]
2. Significant Upregulation of HERV-K (HML-2) Transcription Levels in Human Lung Cancer and Cancer Cells.
Yang C; Guo X; Li J; Han J; Jia L; Wen HL; Sun C; Wang X; Zhang B; Li J; Chi Y; An T; Wang Y; Wang Z; Li H; Li L
Front Microbiol; 2022; 13():850444. PubMed ID: 35359739
[TBL] [Abstract][Full Text] [Related]
3. Identification of the distribution of human endogenous retroviruses K (HML-2) by PCR-based target enrichment sequencing.
Xue B; Zeng T; Jia L; Yang D; Lin SL; Sechi LA; Kelvin DJ
Retrovirology; 2020 May; 17(1):10. PubMed ID: 32375827
[TBL] [Abstract][Full Text] [Related]
4. Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.
Flockerzi A; Ruggieri A; Frank O; Sauter M; Maldener E; Kopper B; Wullich B; Seifarth W; Müller-Lantzsch N; Leib-Mösch C; Meese E; Mayer J
BMC Genomics; 2008 Jul; 9():354. PubMed ID: 18664271
[TBL] [Abstract][Full Text] [Related]
5. Expression of Human Endogenous Retrovirus Group K (HERV-K) HML-2 Correlates with Immune Activation of Macrophages and Type I Interferon Response.
Russ E; Mikhalkevich N; Iordanskiy S
Microbiol Spectr; 2023 Mar; 11(2):e0443822. PubMed ID: 36861980
[TBL] [Abstract][Full Text] [Related]
6. High Expression of HERV-K (HML-2) Might Stimulate Interferon in COVID-19 Patients.
Guo Y; Yang C; Liu Y; Li T; Li H; Han J; Jia L; Wang X; Zhang B; Li J; Li L
Viruses; 2022 May; 14(5):. PubMed ID: 35632738
[No Abstract] [Full Text] [Related]
7. Human Endogenous Retroviruses Long Terminal Repeat Methylation, Transcription, and Protein Expression in Human Colon Cancer.
Dolci M; Favero C; Toumi W; Favi E; Tarantini L; Signorini L; Basile G; Bollati V; D'Alessandro S; Bagnoli P; Ferrante P; Delbue S
Front Oncol; 2020; 10():569015. PubMed ID: 33194657
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional profiling of human endogenous retrovirus group HERV-K(HML-2) loci in melanoma.
Schmitt K; Reichrath J; Roesch A; Meese E; Mayer J
Genome Biol Evol; 2013; 5(2):307-28. PubMed ID: 23338945
[TBL] [Abstract][Full Text] [Related]
9. A human endogenous retrovirus encoded protease potentially cleaves numerous cellular proteins.
Rigogliuso G; Biniossek ML; Goodier JL; Mayer B; Pereira GC; Schilling O; Meese E; Mayer J
Mob DNA; 2019; 10():36. PubMed ID: 31462935
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of human endogenous retrovirus-K (HML-2) mRNAs in hepatoblastoma: Identification of potential new immunotherapeutic targets and biomarkers.
Grabski DF; Ratan A; Gray LR; Bekiranov S; Rekosh D; Hammarskjold ML; Rasmussen SK
J Pediatr Surg; 2021 Feb; 56(2):286-292. PubMed ID: 32682541
[TBL] [Abstract][Full Text] [Related]
11. Characterising a human endogenous retrovirus(HERV)-derived tumour-associated antigen: enriched RNA-Seq analysis of HERV-K(HML-2) in mantle cell lymphoma cell lines.
Tatkiewicz W; Dickie J; Bedford F; Jones A; Atkin M; Kiernan M; Maze EA; Agit B; Farnham G; Kanapin A; Belshaw R
Mob DNA; 2020; 11():9. PubMed ID: 32055257
[TBL] [Abstract][Full Text] [Related]
12. Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals.
Contreras-Galindo R; Kaplan MH; Markovitz DM; Lorenzo E; Yamamura Y
AIDS Res Hum Retroviruses; 2006 Oct; 22(10):979-84. PubMed ID: 17067267
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional profiling of HERV-K(HML-2) in amyotrophic lateral sclerosis and potential implications for expression of HML-2 proteins.
Mayer J; Harz C; Sanchez L; Pereira GC; Maldener E; Heras SR; Ostrow LW; Ravits J; Batra R; Meese E; García-Pérez JL; Goodier JL
Mol Neurodegener; 2018 Aug; 13(1):39. PubMed ID: 30068350
[TBL] [Abstract][Full Text] [Related]
14. The human endogenous retrovirus family HERV-K(HML-3).
Mayer J; Meese EU
Genomics; 2002 Sep; 80(3):331-43. PubMed ID: 12213204
[TBL] [Abstract][Full Text] [Related]
15. Human Endogenous Retrovirus K (HML-2) in Health and Disease.
Xue B; Sechi LA; Kelvin DJ
Front Microbiol; 2020; 11():1690. PubMed ID: 32765477
[TBL] [Abstract][Full Text] [Related]
16. Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection.
Michaud HA; de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF
Retrovirology; 2014 Jan; 11():10. PubMed ID: 24472118
[TBL] [Abstract][Full Text] [Related]
17. Identification of the protease cleavage sites in a reconstituted Gag polyprotein of an HERV-K(HML-2) element.
George M; Schwecke T; Beimforde N; Hohn O; Chudak C; Zimmermann A; Kurth R; Naumann D; Bannert N
Retrovirology; 2011 May; 8():30. PubMed ID: 21554716
[TBL] [Abstract][Full Text] [Related]
18. Human Endogenous Retroviruses-K (HML-2) Expression Is Correlated with Prognosis and Progress of Hepatocellular Carcinoma.
Ma W; Hong Z; Liu H; Chen X; Ding L; Liu Z; Zhou F; Yuan Y
Biomed Res Int; 2016; 2016():8201642. PubMed ID: 28070518
[No Abstract] [Full Text] [Related]
19. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.
Jones RB; Garrison KE; Mujib S; Mihajlovic V; Aidarus N; Hunter DV; Martin E; John VM; Zhan W; Faruk NF; Gyenes G; Sheppard NC; Priumboom-Brees IM; Goodwin DA; Chen L; Rieger M; Muscat-King S; Loudon PT; Stanley C; Holditch SJ; Wong JC; Clayton K; Duan E; Song H; Xu Y; SenGupta D; Tandon R; Sacha JB; Brockman MA; Benko E; Kovacs C; Nixon DF; Ostrowski MA
J Clin Invest; 2012 Dec; 122(12):4473-89. PubMed ID: 23143309
[TBL] [Abstract][Full Text] [Related]
20. Effect of aging on the transcriptomic changes associated with the expression of the HERV-K (HML-2) provirus at 1q22.
Autio A; Nevalainen T; Mishra BH; Jylhä M; Flinck H; Hurme M
Immun Ageing; 2020; 17():11. PubMed ID: 32435269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
